EYPT EyePoint, Inc. - Common Stock
$5,96
Prezzo · Ago 19, 2026
Fondamentali al Ago 5, 2026
Intervallo 52 sett.
$4–$19
13% of range
Rating Analisti
BUY
20 analysts
Prezzo Obiettivo
$37
+514% upside
P/E (TTM)
-1.9
ROE
-84.0%
Margine di Profitto Netto
-739.4%
Informazioni su EyePoint, Inc. - Common Stock Panoramica della società da Wikipedia
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Leggi di più
EyePoint Pharmaceuticals Inc. (formerly pSivida Corporation) is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ). QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.
Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗
EYPT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$5.96
Capitalizzazione di Mercato
$494M
P/E (TTM)
-1.9
EPS (TTM)
$-3.17
Ricavi (TTM)
$31M
Rendimento div.
—
ROE
-84.0%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$4 – $19
EYPT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$31M
2017-06-30
→
2025-12-31
EPS
$-3.17
2017-06-30
→
2025-12-31
Flusso di cassa libero
$-243M
2019-12-31
→
2025-12-31
Margini
-739.4%
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
EYPT
Mediana dei peer
P/E (TTM)
-1.9
29.9
P/S (TTM)
15.7
14.4
P/B
1.6
4.4
Price / FCF (Prezzo / FCF)
-2.0
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
EYPT
Mediana dei peer
Operating Margin (Margine Operativo)
-776.0%
—
Net Profit Margin (Margine di Profitto Netto)
-739.4%
0.70%
ROA
-59.3%
-0.55%
ROE
-84.0%
-2.5%
ROIC
-79.6%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
EYPT
Mediana dei peer
Current Ratio (Rapporto corrente)
8.9
3.9
Quick Ratio
8.3
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
EYPT
Mediana dei peer
Revenue YoY (Ricavi YoY)
-27.5%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
-8.8%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
-1.8%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
EYPT
Mediana dei peer
EYPT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
20 analisti
- Acquisto forte 7 35,0%
- Compra 12 60,0%
- Mantieni 1 5,0%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
13 analisti · 2026-08-19
Mediana
$37.00
← Sotto tutti i target
$5.96
Basso
$8.00
Alto
$68.00
Target mediano
$37.00
+520,8%
Target medio
$36.62
+514,4%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.07%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-1.09 | $-0.97 | -0.12% |
| 31 Marzo 2026 | $-0.99 | $-0.82 | -0.17% |
| 31 Dicembre 2025 | $-0.81 | $-0.76 | -0.05% |
| 30 Settembre 2025 | $-0.85 | $-0.80 | -0.05% |
| 30 Giugno 2025 | $-0.85 | $-0.81 | -0.04% |
| 31 Marzo 2025 | $-0.65 | $-0.67 | 0.02% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | — |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | — |
| CTNM | — | -5.3 | — | — | -27.7% | — |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | — |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| AVIR | $279M | -1.8 | — | — | -49.5% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31M | $43M | $46M | $41M | $37M | $34M | $20M | $5M | $8M | $2M | $27M | |
| R&D Expense | $221M | $133M | $65M | $50M | $28M | $17M | $15M | $19M | $15M | $14M | $12M | |
| SG&A Expense | $52M | $52M | $40M | $35M | $26M | $21M | $18M | $15M | $11M | $9M | $8M | |
| Operating Expenses | $275M | $189M | $121M | $141M | $92M | $72M | $68M | $44M | $26M | $23M | $20M | |
| Operating Income | $-243M | $-146M | $-75M | $-100M | $-55M | $-37M | $-48M | $-39M | $-19M | $-22M | $6M | |
| Interest Expense | · | · | $1M | $3M | $5M | $7M | $6M | $2M | $0 | $0 | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | $19.0K | |
| Other Non-op | $12M | $15M | $7M | $2M | $292.0K | $58.0K | $1M | $420.0K | $91.0K | $72.0K | $22.0K | |
| Pretax Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Income Tax | $279.0K | $90.0K | $83.0K | · | $0 | $0 | $0 | · | $0 | $-155.0K | $96.0K | |
| Net Income | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | $-86M | $-18M | $-22M | $6M | |
| EPS (Basic) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.22 | |
| EPS (Diluted) | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 | · | · | · | $-0.52 | $-0.68 | $0.21 | |
| Shares (Basic) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 29,378,250 | |
| Shares (Diluted) | 73,251 | 56,298 | 38,904 | 37,317,000 | 28,758,000 | · | · | · | 35,343,765 | 31,623,473 | 30,584,140 | |
| EBITDA | $-241M | $-146M | $-75M | $-100M | $-55M | · | $-48M | · | · | $-22M | $6M |
Stato Patrimoniale 27
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $100M | $281M | $96M | $179M | $45M | $22M | $45M | $17M | $15M | $19M | |
| Short-term Investments | $204M | $271M | $50M | $49M | $33M | $0 | $0 | $0 | $0 | $14M | $9M | |
| Inventory | $2M | $2M | $4M | $3M | $4M | $5M | $2M | $279.0K | · | · | · | |
| Prepaid Expense | $20M | $9M | $9M | $10M | $4M | $3M | $6M | $1M | $591.0K | $483.0K | $681.0K | |
| Other Current Assets | $2M | $1M | $1M | $782.0K | $517.0K | · | · | · | · | · | · | |
| Current Assets | $329M | $383M | $345M | $173M | $238M | $63M | $42M | $48M | $18M | $30M | $30M | |
| PP&E (Net) | $9M | $8M | $5M | $1M | $476.0K | $630.0K | $357.0K | $288.0K | $313.0K | $290.0K | $338.0K | |
| PP&E (Gross) | $15M | $12M | $8M | $3M | $2M | $2M | $1M | $983.0K | $799.0K | $2M | $2M | |
| Accum. Depreciation | $6M | $4M | $3M | $2M | $1M | $1M | $839.0K | $695.0K | $486.0K | $2M | $2M | |
| Intangibles | · | · | · | $0 | $23M | $25M | $28M | $30M | $364.0K | $1M | $2M | |
| Other Non-current Assets | $6M | $6M | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Accounts Payable | $10M | $12M | $7M | $6M | $7M | $5M | $4M | $3M | $1M | $1M | $744.0K | |
| Accrued Liabilities | $24M | $18M | $18M | $16M | $14M | $8M | $7M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | $0 | $10M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $37M | $49M | $63M | $35M | $24M | $15M | $12M | $21M | $5M | $5M | $3M | |
| Capital Leases | $21M | $22M | $5M | $6M | $2M | $2M | $3M | $0 | · | · | · | |
| Other Non-current Liabilities | $87.0K | $205.0K | $0 | $600.0K | $2M | $2M | $3M | $1M | $51.0K | · | · | |
| Total Liabilities | $58M | $82M | $89M | $84M | $79M | $73M | $65M | $41M | $5M | $11M | $9M | |
| Long-term Debt | · | · | · | $30M | · | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $40M | $37M | · | $47M | · | · | · | · | |
| Common Stock | $83.0K | $68.0K | $49.0K | $34.0K | $34.0K | $18.0K | $11.0K | $95.0K | $39.0K | $34.0K | $29.0K | |
| Retained Earnings | $-1.10B | $-873M | $-742M | $-671M | $-569M | $-511M | $-465M | $-408M | $-311M | $-292M | $-271M | |
| AOCI | $961.0K | $1M | $864.0K | $786.0K | $841.0K | $841.0K | $840.0K | $839.0K | $833.0K | $852.0K | $945.0K | |
| Stockholders' Equity | $306M | $337M | $266M | $96M | $184M | $19M | $8M | $38M | $13M | $21M | $23M | |
| Liabilities + Equity | $364M | $418M | $355M | $180M | $263M | $92M | $73M | $78M | $19M | $32M | $32M | |
| Shares Outstanding | 82,826,416 | 68,266,005 | 49,043,074 | 34,082,934 | 33,905,826 | 18,139,981 | 10,941,659 | 95,372,236 | 39,356,999 | 34,172,919 | 29,412,365 |
Flusso di cassa 18
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $464.0K | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $28M | $37M | $12M | $14M | $7M | $6M | $5M | · | $2M | $2M | $2M | |
| Deferred Tax | $279.0K | $90.0K | $83.0K | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | $0 | $2M | $2M | $2M | $2M | $981.0K | $724.0K | $756.0K | $770.0K | |
| Restructuring | · | · | · | · | · | $590.0K | · | · | $472.0K | · | · | |
| Other Non-cash | $-39M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-240M | $-126M | $2M | $-65M | $-50M | $-14M | $-57M | · | $-20M | $-16M | $10M | |
| CapEx | $3M | $4M | $3M | $2M | $156.0K | $362.0K | $213.0K | · | $147.0K | $113.0K | $161.0K | |
| Investing Cash Flow | $69M | $-219M | $-3M | $-17M | $-33M | $-362.0K | $-213.0K | · | $14M | $-4M | · | |
| Debt Issued | · | · | $0 | $30M | $0 | · | $50M | · | $0 | $0 | · | |
| Net Debt Issued | · | $0 | $-30M | $-8M | $0 | · | $30M | · | · | · | · | |
| Stock Issued | $173M | $163M | $226M | $0 | · | $50M | $23M | · | $8M | $16M | $0 | |
| Net Stock Activity | $173M | $163M | $226M | · | · | · | $23M | · | · | $16M | · | |
| Financing Cash Flow | $174M | $164M | $187M | $-690.0K | $217M | $37M | $34M | · | $9M | $17M | · | |
| Net Change in Cash | $2M | $-182M | $186M | $-83M | $134M | $23M | $-23M | · | $2M | $-4M | $4M | |
| Taxes Paid | $200.0K | $100.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-243M | $-130M | $-2M | $-67M | $-50M | · | $-57M | · | · | $-16M | $10M | |
| Levered FCF | · | · | $-3M | $-70M | $-56M | · | $-63M | · | · | · | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| Net Margin | -739.4% | -302.4% | -153.8% | -247.0% | -158.1% | · | -278.9% | · | · | -1330.1% | 23.9% | |
| Pretax Margin | -738.5% | -302.2% | -153.7% | -247.0% | -158.1% | · | -278.9% | · | · | -1339.6% | 24.2% | |
| EBITDA Margin | -768.6% | -337.1% | -163.1% | -240.6% | -149.6% | · | -235.0% | · | · | -1344.1% | 24.2% | |
| ROA | -59.3% | -33.8% | -26.4% | -46.1% | -32.9% | · | -75.1% | · | · | -67.3% | 23.1% | |
| ROE | -84.0% | -47.1% | -43.6% | -87.9% | -42.2% | · | -468.1% | · | · | -90.8% | 24.8% | |
| ROIC | -79.6% | -43.4% | -28.2% | -73.2% | -25.0% | · | -86.2% | · | · | -103.5% | 27.1% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 | · | 3.6 | · | · | 5.9 | 8.9 | |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 | · | 1.9 | · | · | 5.7 | 8.5 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.2 | · | 5.7 | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.3 | 0.2 | · | 5.7 | · | · | · | · | |
| Interest Coverage | · | · | -60.2 | -31.2 | -10.1 | · | -7.7 | · | · | · | · |
Efficienza 1
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | · | 0.3 | · | · | 0.1 | 1.0 |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -27.5% | -6.0% | 11.1% | 12.1% | 7.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -8.8% | 5.4% | 10.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $31M | $43M | $46M | $41M | $37M | $34M | $20M | · | $8M | $2M | $27M | |
| Net Income TTM | $-232M | $-131M | $-71M | $-102M | $-58M | $-45M | $-57M | · | $-18M | $-22M | $6M | |
| Market Cap | $1.51B | $509M | $1.13B | $119M | $415M | · | $1.70B | · | · | $967M | $1.11B | |
| Enterprise Value | · | · | $802M | $15M | $240M | · | $1.72B | · | · | · | · | |
| P/E | -5.8 | -3.2 | -12.7 | -1.3 | -6.0 | -9.8 | -23.1 | · | -32.9 | -41.6 | 179.5 | |
| P/S | 48.2 | 11.8 | 24.6 | 2.9 | 11.2 | · | 83.3 | · | · | 597.0 | 41.7 | |
| P/B | 4.9 | 1.5 | 4.3 | 1.2 | 2.3 | · | 203.6 | · | · | 46.3 | 47.5 | |
| P / Tangible Book | 4.9 | 1.5 | 4.3 | 1.2 | 2.6 | · | · | · | · | · | · | |
| P / Cash Flow | -6.3 | -4.0 | 604.5 | -1.8 | -8.3 | · | -29.9 | · | · | -59.3 | 107.7 | |
| P / FCF | -6.2 | -3.9 | -704.8 | -1.8 | -8.3 | · | -29.8 | · | · | -58.9 | 109.4 | |
| EV / EBITDA | · | · | -10.7 | -0.1 | -4.3 | · | -36.0 | · | · | · | · | |
| EV / FCF | · | · | -499.0 | -0.2 | -4.8 | · | -30.2 | · | · | · | · | |
| EV / Revenue | · | · | 17.4 | 0.4 | 6.5 | · | 84.5 | · | · | · | · | |
| Earnings Yield | -17.3% | -31.1% | -7.9% | -78.3% | -16.6% | -10.2% | -4.3% | · | -3.0% | -2.4% | 0.56% |
Conto Economico 16
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $507.0K | $696.0K | $619.0K | $966.0K | $5M | $24M | $12M | $11M | $9M | $12M | $14M | $15M | $9M | $8M | $11M | $10M | |
| Cost of Revenue | · | · | · | · | · | · | · | $736.0K | $1M | $759.0K | · | $1M | $2M | $640.0K | · | · | |
| R&D Expense | $84M | $72M | $59M | $48M | $55M | $59M | $43M | $30M | $30M | $30M | $18M | $17M | $16M | $14M | $16M | $11M | |
| SG&A Expense | $14M | $15M | $11M | $14M | $12M | $14M | $13M | $13M | $13M | $14M | $11M | $11M | $9M | $9M | $8M | $9M | |
| Operating Expenses | $98M | $88M | $71M | $63M | $68M | $73M | $57M | $43M | $44M | $45M | $30M | $30M | $32M | $29M | $54M | $28M | |
| Operating Income | $-97M | $-87M | $-70M | $-62M | $-62M | $-49M | $-45M | $-33M | $-35M | $-33M | $-16M | $-14M | $-23M | $-22M | $-44M | $-18M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $435.0K | $812.0K | $781.0K | $662.0K | |
| Other Non-op | $3M | $2M | $3M | $2M | $3M | $4M | $4M | $3M | $4M | $4M | $2M | $2M | $2M | $1M | $1M | $640.0K | |
| Pretax Income | $-94M | · | $-67M | $-60M | $-59M | · | $-41M | $-29M | $-31M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $-50.0K | $186.0K | $0 | $93.0K | $0 | $90.0K | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-94M | $-85M | $-68M | $-60M | $-59M | $-45M | $-41M | $-29M | $-31M | $-29M | $-14M | $-13M | $-23M | $-21M | $-43M | $-18M | |
| EPS (Basic) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| EPS (Diluted) | $-1.09 | $-0.99 | $-0.82 | $-0.85 | $-0.85 | $-0.65 | $-0.65 | $-0.54 | $-0.58 | $-0.55 | $-0.32 | $-0.33 | $-0.61 | $-0.56 | $-1.17 | $-0.49 | |
| Shares (Basic) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| Shares (Diluted) | 86,543 | 85,999 | -69,833,843 | 70,168 | 69,926 | 69,767 | -52,964,357 | 54,449 | 53,206 | 52,913,000 | -75,915,582 | 38,341,000 | 37,576,000 | 37,486 | -74,596,000 | 37,338,000 | |
| EBITDA | $-97M | $-87M | · | $-62M | $-62M | $-49M | · | $-33M | $-35M | $-33M | · | $-14M | $-23M | $-22M | · | $-18M |
Stato Patrimoniale 27
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $78M | $102M | $75M | $71M | $85M | $100M | $80M | $91M | $271M | $281M | $133M | $140M | $106M | $96M | $75M | |
| Short-term Investments | $70M | $145M | $204M | $129M | $185M | $233M | $271M | $174M | $189M | $28M | $50M | $3M | $3M | $17M | $49M | $82M | |
| Inventory | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | |
| Prepaid Expense | $6M | $25M | $20M | $9M | $6M | $6M | $9M | $12M | $10M | $11M | $9M | $9M | $9M | $9M | $10M | $10M | |
| Other Current Assets | $987.0K | $1M | $2M | $899.0K | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $549.0K | $0 | $0 | $782.0K | · | |
| Current Assets | $189M | $250M | $329M | $216M | $265M | $327M | $383M | $269M | $295M | $318M | $345M | $150M | $167M | $146M | $173M | $192M | |
| PP&E (Net) | $10M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $1M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $12M | · | · | · | $8M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Other Non-current Assets | $9M | $9M | $6M | $6M | $6M | $6M | $6M | $2M | · | · | $0 | · | · | · | · | · | |
| Total Assets | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Accounts Payable | $17M | $19M | $10M | $10M | $20M | $16M | $12M | $7M | $14M | $7M | $7M | $10M | $11M | $9M | $6M | $6M | |
| Accrued Liabilities | $22M | $16M | $24M | $18M | $11M | $18M | $18M | $14M | $13M | $16M | $18M | $13M | $15M | $10M | $16M | $16M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $5M | $10M | $10M | |
| Current Liabilities | $42M | $37M | $37M | $30M | $33M | $42M | $49M | $49M | $62M | $63M | $63M | $64M | $69M | $27M | $35M | $34M | |
| Capital Leases | $20M | $20M | $21M | $21M | $22M | $22M | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Other Non-current Liabilities | $23.0K | $55.0K | $87.0K | $118.0K | $148.0K | $177.0K | $205.0K | $233.0K | · | · | $0 | $0 | $0 | $600.0K | $600.0K | $600.0K | |
| Total Liabilities | $62M | $58M | $58M | $52M | $55M | $64M | $82M | $82M | $96M | $79M | $89M | $101M | $118M | $76M | $84M | $84M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | · | $30M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $35M | · | $40M | |
| Common Stock | $85.0K | $83.0K | $83.0K | $70.0K | $69.0K | $69.0K | $68.0K | $53.0K | $52.0K | $50.0K | $49.0K | $35.0K | $34.0K | $34.0K | $34.0K | $34.0K | |
| Retained Earnings | $-1.28B | $-1.19B | $-1.10B | $-1.04B | $-978M | $-918M | $-873M | $-832M | $-802M | $-771M | $-742M | $-728M | $-715M | $-693M | $-671M | $-628M | |
| AOCI | $793.0K | $802.0K | $961.0K | $919.0K | $832.0K | $923.0K | $1M | $1M | $792.0K | $836.0K | $864.0K | $841.0K | $842.0K | $843.0K | $786.0K | $653.0K | |
| Stockholders' Equity | $166M | $230M | $306M | $200M | $246M | $298M | $337M | $219M | $228M | $250M | $266M | $59M | $57M | $78M | $96M | $136M | |
| Liabilities + Equity | $228M | $288M | $364M | $252M | $301M | $363M | $418M | $301M | $324M | $329M | $355M | $160M | $176M | $155M | $180M | $220M | |
| Shares Outstanding | 84,981,843 | 83,453,001 | 82,826,416 | 69,569,813 | 68,889,649 | 68,811,357 | 68,266,005 | 53,524,364 | 52,160,305 | 49,885,701 | 49,043,074 | 35,309,432 | 34,306,118 | 34,301,926 | 34,082,934 | 34,072,155 |
Flusso di cassa 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $690.0K | $636.0K | $698.0K | $576.0K | $538.0K | $497.0K | $467.0K | $408.0K | $362.0K | $303.0K | $112.0K | · | · | · | · | · | |
| Stock-based Comp | $10M | $12M | $7M | $6M | $7M | $8M | $8M | $7M | $9M | $13M | $4M | $4M | $2M | $3M | $3M | $3M | |
| Deferred Tax | · | · | $369.0K | $0 | · | · | $90.0K | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $205.0K | $615.0K | |
| Other Non-cash | · | $-8M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-81M | $-65M | $-59M | $-63M | $-53M | $-36M | $-39M | $-20M | $-31M | $-23M | $-15M | $57M | $-17M | $-13M | $-13M | |
| CapEx | $1M | $997.0K | $986.0K | $798.0K | $1M | $276.0K | $384.0K | $2M | $900.0K | $1M | $883.0K | $2M | $396.0K | $484.0K | $585.0K | $1M | |
| Investing Cash Flow | $75M | $59M | $-75M | $55M | $48M | $40M | $-96M | $16M | $-160M | $21M | $-47M | $-2M | $13M | $32M | $33M | $6M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $167M | $7M | · | · | $152M | · | · | · | $216M | · | · | · | $0 | · | |
| Financing Cash Flow | $20M | $-3M | $167M | $7M | $238.0K | $-951.0K | $152M | $12M | $329.0K | $115.0K | $218M | $10M | $-37M | $-5M | $-58.0K | $92.0K | |
| Net Change in Cash | $33M | $-24M | $27M | $3M | $-14M | $-15M | $20M | $-11M | $-180M | $-10M | $148M | $-7M | $34M | $10M | $20M | $-7M | |
| Free Cash Flow | · | $-82M | · | · | · | $-53M | · | · | · | $-32M | · | · | · | $-17M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19207.1% | -12532.5% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| Net Margin | -18633.1% | -12188.5% | · | -6183.4% | -1114.3% | -184.8% | · | -279.0% | -325.3% | -250.6% | · | -83.0% | -251.7% | -275.5% | · | -184.0% | |
| Pretax Margin | -18633.1% | · | · | -6183.4% | -1112.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -19207.1% | -12441.1% | · | -6420.8% | -1166.8% | -199.7% | · | -311.2% | -364.5% | -285.2% | · | -94.7% | -250.0% | -280.5% | · | -183.8% | |
| ROA | -35.7% | -26.1% | · | -21.6% | -19.0% | -13.1% | · | -12.7% | -12.3% | -12.1% | · | -6.6% | -11.2% | -10.6% | · | -9.5% | |
| ROE | -45.8% | -32.1% | · | -28.5% | -25.1% | -16.5% | · | -21.2% | -21.6% | -17.8% | · | -12.9% | -22.0% | -17.3% | · | -16.1% | |
| ROIC | -58.5% | · | · | -31.0% | -25.3% | · | · | · | · | · | · | · | · | · | · | · |
Liquidità e Solvibilità 5
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 6.7 | · | 7.2 | 8.0 | 7.8 | · | 5.5 | 4.7 | 5.1 | · | 2.4 | 2.4 | 5.4 | · | 5.6 | |
| Quick Ratio | 4.3 | 5.9 | · | 6.8 | 7.7 | 7.6 | · | 5.2 | 4.5 | 4.8 | · | 2.1 | 2.1 | 4.5 | · | 4.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | -52.3 | -26.5 | · | -27.8 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.2 | 0.4 | 0.2 | · | · | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $31M | · | $41M | $50M | $56M | · | $47M | $45M | $44M | · | $42M | $38M | $39M | · | $40M | |
| Net Income TTM | $-298M | $-249M | · | $-194M | $-165M | $-135M | · | $-102M | $-96M | $-86M | · | $-75M | $-82M | $-80M | · | $-75M | |
| Market Cap | $1.22B | $1.08B | · | $991M | $648M | $373M | · | $428M | $454M | $1.03B | · | $282M | $298M | $101M | · | $270M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $146M | $156M | $13M | · | $152M | |
| P/E | -3.8 | -3.9 | · | -4.9 | -3.6 | -2.3 | · | -4.0 | -4.2 | -10.1 | · | -4.0 | -4.0 | -1.4 | · | -3.7 | |
| P/S | 162.0 | 34.2 | · | 24.0 | 13.0 | 6.6 | · | 9.1 | 10.0 | 23.6 | · | 6.7 | 7.8 | 2.6 | · | 6.7 | |
| P/B | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.0 | |
| P / Tangible Book | 7.3 | 4.7 | · | 4.9 | 2.6 | 1.2 | · | 2.0 | 2.0 | 4.1 | · | 4.8 | 5.2 | 1.3 | · | 2.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -7.0 | · | · | · | -33.1 | · | · | · | -6.0 | · | · | |
| P / FCF | · | -13.2 | · | · | · | -7.0 | · | · | · | -31.9 | · | · | · | -5.8 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -10.1 | -6.9 | -0.6 | · | -8.3 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | -0.8 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 3.5 | 4.1 | 0.3 | · | 3.8 | |
| Earnings Yield | -26.4% | -25.9% | · | -20.3% | -27.8% | -42.8% | · | -25.0% | -23.8% | -9.9% | · | -24.9% | -25.1% | -72.5% | · | -27.2% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $31M | $43M | $46M | $41M | $37M |
| Margine Operativo % | -776.0% | -337.1% | -163.1% | -240.6% | -149.6% |
| Utile netto | $-232M | $-131M | $-71M | $-102M | $-58M |
| EPS Diluito | $-3.17 | $-2.32 | $-1.82 | $-2.74 | $-2.03 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | — | — | 0.0 | 0.4 | 0.2 |
| Rapporto corrente | 8.9 | 7.8 | 5.5 | 5.0 | 10.0 |
| Quick Ratio | 8.3 | 7.6 | 5.2 | 4.2 | 8.9 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-243M | $-130M | $-2M | $-67M | $-50M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 217 filer · $1.2B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 37 (-25 vs trimestre precedente) | 21 (-2 vs trimestre precedente) | 63 (-9 vs trimestre precedente) | 56 (+18 vs trimestre precedente) | +3.1M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $118.638.163 | 8.296.375 | 10,19% | Azioni |
| Cormorant Asset Management, LP | $100.100.000 | 7.000.000 | 8,60% | Azioni |
| VANGUARD GROUP INC | $78.353.343 | 4.288.634 | 6,73% | Azioni |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $69.037.426 | 4.827.792 | 5,93% | Azioni |
| Commodore Capital LP | $65.780.000 | 4.600.000 | 5,65% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $51.912.604 | 3.630.252 | 4,46% | Azioni |
| JANUS HENDERSON GROUP PLC | $45.962.750 | 3.565.768 | 3,95% | Azioni |
| Paradigm Biocapital Advisors LP | $41.332.677 | 2.890.397 | 3,55% | Azioni |
| STATE STREET CORP | $33.712.894 | 2.357.545 | 2,90% | Azioni |
| Aberdeen Group plc | $28.725.869 | 2.008.802 | 2,47% | Azioni |
| PERCEPTIVE ADVISORS LLC | $28.600.000 | 2.000.000 | 2,46% | Opzione Put |
| Balyasny Asset Management L.P. | $25.916.719 | 1.812.358 | 2,23% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $25.269.659 | 1.766.745 | 2,17% | Azioni |
| CITADEL ADVISORS LLC | $25.214.389 | 1.763.244 | 2,17% | Azioni |
| Parkman Healthcare Partners LLC | $18.420.731 | 1.288.163 | 1,58% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.811.837 | 1.245.583 | 1,53% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $16.890.345 | 1.181.143 | 1,45% | Azioni |
| Essex Woodlands Management, Inc. | $15.513.455 | 1.084.857 | 1,33% | Azioni |
| ORBIMED ADVISORS LLC | $15.288.802 | 1.069.147 | 1,31% | Azioni |
| 5AM Venture Management, LLC | $15.015.000 | 1.050.000 | 1,29% | Azioni |
| Rosalind Advisors, Inc. | $14.131.689 | 988.230 | 1,21% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $13.885.500 | 971.014 | 1,19% | Azioni |
| HSBC HOLDINGS PLC | $11.918.407 | 833.455 | 1,02% | Azioni |
| Candriam S.C.A. | $11.254.258 | 787.769 | 0,97% | Azioni |
| AMERIPRISE FINANCIAL INC | $11.087.640 | 775.357 | 0,95% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $11.062.981 | 773.635 | 0,95% | Azioni |
| Artia Global Partners LP | $10.969.501 | 767.098 | 0,94% | Azioni |
| Blue Owl Capital Holdings LP | $10.905.094 | 762.594 | 0,94% | Azioni |
| Patient Square Capital LP | $10.296.000 | 720.000 | 0,88% | Azioni |
| Principia Wealth Advisory, LLC | $9.696.346 | 530.725 | 0,83% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.260.866 | 647.613 | 0,80% | Azioni |
| Sio Capital Management, LLC | $8.910.759 | 623.130 | 0,77% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $7.996.789 | 559.216 | 0,69% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.899.320 | 552.400 | 0,68% | Opzione Call |
| Alyeska Investment Group, L.P. | $7.284.463 | 509.403 | 0,63% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $7.151.330 | 500.093 | 0,61% | Azioni |
| Simplify Asset Management Inc. | $5.720.629 | 400.044 | 0,49% | Azioni |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Opzione Call |
| Ikarian Capital, LLC | $5.296.720 | 370.400 | 0,46% | Opzione Put |
| Ghisallo Capital Management LLC | $5.005.000 | 350.000 | 0,43% | Azioni |
| STEMPOINT CAPITAL LP | $4.840.135 | 338.471 | 0,42% | Azioni |
| E Fund Management Co., Ltd. | $4.730.068 | 330.774 | 0,41% | Azioni |
| Jump Financial, LLC | $4.586.825 | 320.757 | 0,39% | Azioni |
| Bleichroeder LP | $4.526.165 | 316.515 | 0,39% | Azioni |
| Woodline Partners LP | $4.296.621 | 300.463 | 0,37% | Azioni |
| Eversept Partners, LP | $4.257.610 | 297.735 | 0,37% | Azioni |
| GOLDMAN SACHS GROUP INC | $4.086.797 | 285.790 | 0,35% | Azioni |
| Rock Springs Capital Management LP | $3.839.822 | 268.519 | 0,33% | Azioni |
| CITIGROUP INC | $3.750.032 | 262.240 | 0,32% | Azioni |
| MYDA Advisors LLC | $3.575.000 | 250.000 | 0,31% | Azioni |
| AXA Investment Managers S.A. | $3.480.640 | 244.427 | 0,30% | Azioni |
| UBS Group AG | $3.373.442 | 235.905 | 0,29% | Azioni |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $3.342.639 | 233.751 | 0,29% | Azioni |
| Schonfeld Strategic Advisors LLC | $3.285.853 | 229.780 | 0,28% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.038.750 | 212.500 | 0,26% | Opzione Put |
| Propel Bio Management, LLC | $2.741.954 | 191.745 | 0,24% | Azioni |
| Qube Research & Technologies Ltd | $2.704.159 | 189.102 | 0,23% | Azioni |
| Walleye Capital LLC | $2.691.560 | 188.221 | 0,23% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $2.685.554 | 187.801 | 0,23% | Azioni |
| BlackRock, Inc. | $2.649.890 | 185.307 | 0,23% | Azioni |
| CITADEL ADVISORS LLC | $2.559.700 | 179.000 | 0,22% | Opzione Put |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $2.389.303 | 169.334 | 0,21% | Azioni |
| HighVista Strategies LLC | $2.226.567 | 155.704 | 0,19% | Azioni |
| Granahan Investment Management, LLC | $2.136.234 | 149.387 | 0,18% | Azioni |
| Swiss National Bank | $2.034.890 | 142.300 | 0,17% | Azioni |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.998.711 | 139.770 | 0,17% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $1.890.660 | 132.214 | 0,16% | Azioni |
| Corient Private Wealth LP | $1.827.526 | 127.799 | 0,16% | Azioni |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $1.740.081 | 121.684 | 0,15% | Azioni |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Opzione Call |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.548.690 | 108.300 | 0,13% | Opzione Put |
| DIADEMA PARTNERS LP | $1.520.090 | 106.300 | 0,13% | Opzione Call |
| SILVERBACK ASSET MANAGEMENT LLC | $1.430.000 | 100.000 | 0,12% | Opzione Call |
| Squarepoint Ops LLC | $1.401.429 | 98.002 | 0,12% | Azioni |
| RHUMBLINE ADVISERS | $1.393.341 | 97.437 | 0,12% | Azioni |
| CITADEL ADVISORS LLC | $1.357.070 | 94.900 | 0,12% | Opzione Call |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.354.752 | 105.101 | 0,12% | Azioni |
| ALGERT GLOBAL LLC | $1.129.557 | 78.990 | 0,10% | Azioni |
| Waverly Advisors, LLC | $1.114.170 | 77.914 | 0,10% | Azioni |
| Cinctive Capital Management LP | $1.037.923 | 72.582 | 0,09% | Azioni |
| Caption Management, LLC | $1.036.750 | 72.500 | 0,09% | Opzione Call |
| WELLINGTON MANAGEMENT GROUP LLP | $1.035.134 | 72.387 | 0,09% | Azioni |
| GOLDMAN SACHS GROUP INC | $1.002.430 | 70.100 | 0,09% | Opzione Call |
| DEUTSCHE BANK AG\ | $989.860 | 69.221 | 0,09% | Azioni |
| Bank of New York Mellon Corp | $981.824 | 68.659 | 0,08% | Azioni |
| WOODSTOCK CORP | $979.049 | 68.465 | 0,08% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $971.081 | 75.336 | 0,08% | Azioni |
| BANK OF AMERICA CORP /DE/ | $930.186 | 65.048 | 0,08% | Azioni |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $865.708 | 60.539 | 0,07% | Azioni |
| FOX RUN MANAGEMENT, L.L.C. | $836.950 | 58.528 | 0,07% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $732.017 | 51.190 | 0,06% | Azioni |
| SILVERBACK ASSET MANAGEMENT LLC | $715.000 | 50.000 | 0,06% | Azioni |
| JANE STREET GROUP, LLC | $715.000 | 50.000 | 0,06% | Opzione Call |
| Erste Asset Management GmbH | $705.500 | 50.000 | 0,06% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $702.545 | 49.129 | 0,06% | Azioni |
| Point72 Asset Management, L.P. | $694.608 | 48.574 | 0,06% | Azioni |
| SBI Okasan Asset Management Co.Ltd. | $644.827 | 45.700 | 0,06% | Azioni |
| MetLife Investment Management, LLC | $621.607 | 43.469 | 0,05% | Azioni |
| JANE STREET GROUP, LLC | $597.954 | 41.815 | 0,05% | Azioni |
| SCOTIA CAPITAL INC. | $597.039 | 41.751 | 0,05% | Azioni |
Insider aziendali 25 insider · 12 dirigenti · 16 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jay S. Duker | President and CEO | 10 Luglio 2026 M | 9.594 | 0 | 0 | $0 |
| Nancy Lurker | President & CEO | 12 Ottobre 2018 A | 211.700 | 0 | 0 | $0 |
| Paul Ashton | President & CEO | 18 Marzo 2016 M | 450.741 | 0 | 0 | $0 |
| David Price | Chief Financial Officer | 01 Agosto 2018 A | — | 0 | 0 | $0 |
| Michael Soja | VP Finance, CFO & Treasurer | 10 Settembre 2008 A | — | 0 | 0 | $0 |
| Ramiro Ribeiro | Chief Medical Officer | 30 Giugno 2026 M | 0 | 0 | 2 | $-73.174 |
| Leonard S Ross | Vice President of Finance and Chief Accounting Officer | 22 Dicembre 2018 M | 76.187 | 0 | 0 | $0 |
| Dario A. Paggiarino | Chief Medical Officer | 12 Ottobre 2018 F | 29.600 | 0 | 0 | $0 |
| Leonard M Blum | Executive VP and General Manager, US | 14 Maggio 2018 A | — | 0 | 0 | $0 |
| Debora Jorn | EVP, Corp. & Comm'l Dev. | 27 Giugno 2017 A | — | 0 | 0 | $0 |
| Lori Freedman | VP Corporate Affairs, General Counsel and Secretary | 21 Luglio 2016 A | 96.423 | 0 | 0 | $0 |
| Aaron Finlay | Secretary | 18 Ottobre 2007 A | — | 0 | 0 | $0 |
| Karen L. Zaderej | Direttore | 18 Agosto 2026 P | 49.100 | 1 | 0 | $52.258 |
| Wendy F Dicicco | Direttore | 02 Gennaio 2026 A | — | 0 | 0 | $0 |
| ANDO GORAN | Direttore | 02 Gennaio 2026 A | — | 0 | 0 | $0 |
| Fred Hassan | Direttore | 02 Gennaio 2026 A | — | 0 | 0 | $0 |
| Michael W Rogers | Direttore | 15 Novembre 2018 M | 112.500 | 0 | 0 | $0 |
| John B. Landis | Direttore | 25 Ottobre 2018 A | — | 0 | 0 | $0 |
| David J Mazzo | Direttore | 06 Settembre 2018 A | 138.000 | 0 | 0 | $0 |
| Douglas Evan Godshall | Direttore | 27 Giugno 2018 M | 12.500 | 0 | 0 | $0 |
| James J Barry | Direttore | 07 Maggio 2018 M | 12.500 | 0 | 0 | $0 |
| Kristine Peterson | Direttore | 15 Dicembre 2017 A | — | 0 | 0 | $0 |
| SAVAS PETER G | Direttore | 03 Dicembre 2015 A | — | 0 | 0 | $0 |
| Paul Hopper | Direttore | 18 Dicembre 2013 A | 10.000 | 0 | 0 | $0 |
| Katherine Woodthorpe | Direttore | 27 Novembre 2007 A | — | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| EW Healthcare Partners L.P., EW Healthcare Partners-A L.P., Essex Woodlands Fund IX-GP, L.P., Essex Woodlands IX, LLC, Martin P. Sutter, R. Scott Barry, Ronald Eastman, Petri Vainio, Steve Wiggins ×4 depositi | 08 Dicembre 2023 | — | Deposito iniziale | — | SEC |
| Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata, Persona segnalante non divulgata | 30 Agosto 2023 | — | Deposito iniziale | — | SEC |
| Ocumension Therapeutics | 22 Gennaio 2021 | — | Deposito iniziale | — | SEC |
| IRS Identification Nos. of above persons (entities only) Pfizer Inc. ×2 depositi | 26 Maggio 2017 | — | Deposito iniziale | — | SEC |
| Pfizer Inc. | 17 Luglio 2007 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 42 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,18% | 11.564 NS | 30 Aprile 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,61% | 17.260 NS | 30 Aprile 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,12% | 25.180 NS | 31 Maggio 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,08% | 78.250 NS | 30 Aprile 2026 | N-PORT |
| BIB · ProShares Trust | 0,06% | 3.062 NS | 31 Maggio 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 25.575 NS | 31 Maggio 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 33.518 NS | 30 Aprile 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 3.648 NS | 31 Maggio 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 378.469 NS | 31 Maggio 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 34.174 NS | 30 Aprile 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.853 NS | 31 Maggio 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 152.391 NS | 30 Aprile 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 2.885 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2.895 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 72 NS | 31 Maggio 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 28.026 NS | 31 Maggio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3.564 NS | 30 Aprile 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.188 NS | 31 Maggio 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10.667 NS | 30 Aprile 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 41.879 NS | 30 Aprile 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 13.282 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Luglio 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Luglio 2026 | Giornaliero |
| ITOT · iShares Trust | — | — | 22 Luglio 2026 | Giornaliero |
| IWV · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | — | — | 17 Agosto 2026 | Giornaliero |
| IWO · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWM · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IWC · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| IHE · iShares Trust | — | — | 18 Agosto 2026 | Giornaliero |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 Luglio 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | — | — | 20 Luglio 2026 | Giornaliero |
| ISCB · iShares Trust | — | — | 20 Luglio 2026 | Giornaliero |
| ISCV · iShares Trust | — | — | 20 Luglio 2026 | Giornaliero |
| WSML · iShares Trust | — | — | 20 Luglio 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 Luglio 2026 | Giornaliero |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 05 Agosto 2026 | Giornaliero |